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ABSTRACT Aspergillus nidulans is an opportunistic fungal pathogen in patients with
immunodeficiency, and virulence of A. nidulans isolates has mainly been studied in
the context of chronic granulomatous disease (CGD), with characterization of clinical
isolates obtained from non-CGD patients remaining elusive. This study therefore car-
ried out a detailed biological characterization of two A. nidulans clinical isolates (CIs),
obtained from a patient with breast carcinoma and pneumonia and from a patient
with cystic fibrosis that underwent lung transplantation, and compared them to the
reference, nonclinical FGSC A4 strain. Both CIs presented increased growth in com-
parison to that of the reference strain in the presence of physiologically relevant car-
bon sources. Metabolomic analyses showed that the three strains are metabolically
very different from each other in these carbon sources. Furthermore, the CIs were
highly susceptible to cell wall-perturbing agents but not to other physiologically rel-
evant stresses. Genome analyses identified several frameshift variants in genes en-
coding cell wall integrity (CWI) signaling components. Significant differences in CWI
signaling were confirmed by Western blotting among the three strains. In vivo viru-
lence studies using several different models revealed that strain MO80069 had sig-
nificantly higher virulence in hosts with impaired neutrophil function than the other
strains. In summary, this study presents detailed biological characterization of
two A. nidulans sensu stricto clinical isolates. Just as in Aspergillus fumigatus,
strain heterogeneity exists in A. nidulans clinical strains that can define virulence
traits. Further studies are required to fully characterize A. nidulans strain-specific
virulence traits and pathogenicity.
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IMPORTANCE Immunocompromised patients are susceptible to infections with op-
portunistic filamentous fungi from the genus Aspergillus. Although A. fumigatus is
the main etiological agent of Aspergillus species-related infections, other species,
such as A. nidulans, are prevalent in a condition-specific manner. A. nidulans is a pre-
dominant infective agent in patients suffering from chronic granulomatous disease
(CGD). A. nidulans isolates have mainly been studied in the context of CGD although
infection with A. nidulans also occurs in non-CGD patients. This study carried out a
detailed biological characterization of two non-CGD A. nidulans clinical isolates and
compared the results to those with a reference strain. Phenotypic, metabolomic, and
genomic analyses highlight fundamental differences in carbon source utilization,
stress responses, and maintenance of cell wall integrity among the strains. One clini-
cal strain had increased virulence in models with impaired neutrophil function. Just
as in A. fumigatus, strain heterogeneity exists in A. nidulans clinical strains that can
define virulence traits.
KEYWORDS Aspergillus nidulans, clinical isolates, genome sequencing, metabolomics
Fungal pathogen-related infections are now estimated to result in a higher numberof human deaths than tuberculosis or malaria alone (1–3). The majority of systemic
fungal infections are caused by Candida spp., Pneumocystis spp., Cryptococcus spp., and
Aspergillus spp. (4, 5). Of the hundreds of known Aspergillus spp., only a few cause
disease in animals, with the most prominent being Aspergillus fumigatus, Aspergillus
flavus, Aspergillus nidulans, Aspergillus niger, and Aspergillus terreus (6, 7).
The primary route of infection of Aspergillus spp. is via the inhalation of conidia
(asexual spores). In immunocompetent individuals, inhaled conidia are rapidly cleared
by pulmonary resident and recruited neutrophils and macrophages, together prevent-
ing the onset of infection (8–10). However, disturbances to the immune system may
render an individual susceptible to infection by Aspergillus spp. (11). The severity of
infection largely depends on fungal species and genotype, the host immunological
status, and host lung structure (6). Invasive aspergillosis (IA) is the most severe disease
caused by Aspergillus spp. and is characterized by systemic host invasion, resulting in
high mortality rates (30 to 95%) (2, 10, 11).
Patient populations with a highest risk of IA are (i) those with prolonged neutro-
penia from intensive myeloablative chemotherapy, (ii) cancer patients who are immu-
nosuppressed due to chemotherapy and/or radiotherapy, (iii) those with cystic fibrosis,
a hereditary disease that affects the lungs, (iv) and those with genetic disorders
resulting in primary immune deficiencies, such as chronic granulomatous disease (CGD)
(12, 13). CGD is a genetic disorder that affects 1 in 250,000 people, and in 80% of all
cases subjects are of the male sex. CGD is caused by mutations in the genes encoding
any of the five structural components of the NADPH-oxidase complex, an enzyme
complex important for superoxide anion and downstream reactive oxygen species
(ROS) production in phagocytic cells (14). As a result, immune cells are unable to
efficiently kill microorganisms, and these microorganisms can then become pathogenic
in such patients (13, 14)
Although A. fumigatus is the main etiological agent of Aspergillus-related infections
in immunocompromised patients, other Aspergillus spp. have been found to have a
high infection rate under some conditions. A. nidulans infections are not commonly
reported in immunocompromised patients, except for subjects suffering from CGD (15,
16). In CGD patients, A. fumigatus and A. nidulans are responsible for 44% and 23%,
respectively, of all fungal infections (15, 16). Infections with A. nidulans cause mortality
in 27 to 32% of CGD patients (15), and in comparison to A. fumigatus, A. nidulans
isolates have high virulence, invasiveness, dissemination, and resistance to antifungal
drugs in these patients (17). Hence, A. nidulans infections have been studied mainly in
the context of CGD although this fungal species can also be virulent in non-CGD,
immunocompromised patients (18). In comparison to research on A. fumigatus, inves-
tigations into A. nidulans isolate virulence have been neglected, with very few studies
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having investigated the genetic and metabolic features of A. nidulans clinical strains,
isolated from CGD and non-CGD patients, in the context of stress responses encoun-
tered during human host infection as well as during interactions with host immune
responses (18–21).
The aim of this work was to carry out a detailed molecular, phenotypic, and
virulence characterization of two A. nidulans clinical isolates (CIs) from (i) a patient with
breast carcinoma and pneumonia and (ii) a patient with cystic fibrosis who underwent
lung transplantation and to compare the results to those with the well-characterized,
wild-type isolate FGSC A4 (A4).
RESULTS
A. nidulans clinical isolates have increased growth in comparison to that of the
reference strain in the presence of alternative carbon sources. Fungal metabolic
plasticity, which allows growth in unique and diverse ambient and host microenviron-
ments, has long been hypothesized to contribute to Aspergillus virulence, with carbon
sources such as glucose (22), ethanol (23), and acetate (24) being predicted to be
actively used during in vivo infection. In addition, fatty acids and lipids are also thought
to serve as major nutrient sources during mammalian host colonization, as is evident
by the importance of key glyoxylate cycle enzymes in fungal virulence (25). We
therefore characterized growth by determining the fungal dry weight of the two A.
nidulans CIs in the presence of minimal medium (MM) supplemented with different
physiologically relevant carbon sources, namely, glucose, acetate, ethanol, and lipids,
and compared the results to those with the FGSC A4 reference strain. A significant
reduction in growth was observed for both CIs in the presence of glucose, whereas
both CIs had significantly increased growth in the presence of the alternative carbon
sources ethanol, Casamino Acids, and the lipids Tween 20 (a source of lauric, palmitic,
and myristic acids) (26), Tween 80 (which contains principally oleate) (26), and olive oil
(triacylglycerols and free fatty acids) (27) (Fig. 1). In contrast, no difference in fungal
biomass accumulation was observed in the presence of acetate and the lung-resident
glycoprotein mucin (Fig. 1). These results suggest that the A. nidulans CIs have im-
proved growth relative to that of the reference strain in the presence of most of the
alternative carbon sources tested here, including different lipids.
Metabolic profiles differ among the A. nidulans clinical isolates and the refer-
ence strain in the presence of different carbon sources. To further investigate
nutrient utilization in the A. nidulans CIs, the metabolic profiles of strains MO80069 and
SP-2605-48 were determined and compared to the profile of the reference strain A4.
FIG 1 The A. nidulans clinical isolates exhibit improved growth in the presence of alternative carbon and
lipid sources. Strains were grown in liquid MM supplemented with glucose, acetate, ethanol, mucin,
Tween 20 and 80, olive oil, and Casamino Acids at 37°C for 48 h (glucose) or 72 h (others) before fungal
biomass was freeze-dried and weighed. Standard deviations were determined from biological triplicates
in a one-way ANOVA with Tukey’s posttest comparing growth of the clinical isolates to that of the FGSC
A4 reference strain (*, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001).
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Metabolomics was carried out on cellular extracts from strains grown for 24 h in
fructose-rich MM and then transferred for 16 h to MM supplemented with glucose (CIs
present reduced growth), ethanol (CIs had increased growth), acetate, and mucin (no
difference in growth profiles). A total of 40 different metabolites were identified when
strains were grown in the presence of glucose and ethanol, whereas 44 different
metabolites were identified when strains were grown in the presence of acetate and
mucin (see Table S1; all supplemental material is posted at https://doi.org/10.6084/m9
.figshare.11973936). In a comparison of the metabolite quantities of strain MO80069 to
those of the reference strain, 18 (45%), 22 (55%), 23 (52%), and 24 (55%) metabolite
quantities were significantly (P value of 0.05) different from the quantities in the
reference strain when strains were grown in glucose, ethanol, acetate, and mucin,
respectively (Table 1; see also Table S1). In strain SP-2505-48, 15 (38%), 23 (58%), 30
(68%), and 14 (32%) metabolite quantities, which were normalized by fungal dry
weight, were significantly (P value of 0.05) different from the quantities in the
reference strain in the presence of glucose, ethanol, acetate, and mucin, respectively
(Table 1; see also Table S1). Principal-component analysis (PCA) and hierarchical
clustering analysis (HCA) of identified metabolite quantities showed that the CIs
clustered apart from the reference strain and from each other in all tested carbon
sources (see Fig. S1 and S2 at the URL mentioned above), indicating that they are
metabolically different from the reference strain and from each other.
When we further focused on metabolites that were significantly different in quantity
between the CIs and the reference strain, we observed that in the presence of glucose
and ethanol, the majority of identified metabolites were present in significantly lower
quantities than in the reference strain whereas both CIs had significantly higher
metabolite quantities in the presence of acetate than the reference strain (Fig. 2A to C).
Furthermore, when the A. nidulans CIs were cultivated in mucin-rich minimal medium,
only 9 out of 29 significantly different metabolite quantities were identified in both
strains whereas the remaining metabolite quantities were strain specific, suggesting
that the metabolic profiles of the two differed drastically in the presence of this carbon
source (Fig. 2D).
When the CIs were grown in a glucose-rich MM, amino acids were found in lower
quantities in both CIs than in the reference strain. In contrast, pentose phosphate
pathway (PPP) intermediates, glycerol, glycerol derivatives, and aromatic amino acids
were detected in significantly higher quantities in this carbon source (Fig. 2A). In an
ethanol-rich MM, significantly lower quantities of various amino acids as well as of the
citric acid cycle intermediate citrate were detected in the CIs whereas increased
quantities of several amino acid pathway intermediates, the carbon compounds glyc-
erol, mannitol, and trehalose, PPP intermediates, and lactate were detected in the CIs
compared to levels in the reference strain grown in this carbon source (Fig. 2C). In
acetate-rich MM, most identified metabolites, notably a variety of amino acids, were
present in significantly larger amounts in the CIs than in the reference strain, with the
exception of some amino acids, PPP intermediates, spermidine, rhamnose, and urea
(Fig. 2B). When strains were grown in mucin-rich MM, differences in the quantities of a
variety of amino acids were observed, whereas trehalose was present in significantly
TABLE 1 Number and percentage of identified metabolite quantities that were
significantly different in the A. nidulans clinical isolatesa
Carbon source (n)b
No. (%) of differentially produced metabolites
MO80069 vs FGSC A4 SP-2605-48 vs FGSC A4
Glucose (40) 18 (45) 15 (38)
Ethanol (40) 22 (55) 23 (58)
Acetate (44) 23 (52) 30 (68)
Mucin (44) 24 (55) 14 (32)
aMetabolite quantities in A. nidulans clinical isolates were compared to those of the reference strain
(P  0.05). Strains were grown in the presence of the indicated carbon source for 16 h.
bn, number of metabolites tested.
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FIG 2 The A. nidulans clinical isolates are metabolically different from the reference strain in the presence of different carbon sources. (A to D) Heat maps
depicting log fold changes of identified metabolite quantities that were significantly (P  0.05) different in the A. nidulans clinical isolates MO80069 and
SP-2605-48 compared to levels in the FGSC A4 reference strain (gray squares depict metabolite quantities that were not detected as significantly different in
one of the clinical isolates).
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lower quantities and urea was present in significantly higher quantities in both CIs than
in the reference strain (Fig. 2D). In summary, these results suggest significant differ-
ences in amino acid biosynthesis and degradation, carbon source storage compounds,
and degradation among the different A. nidulans strains in a condition-dependent
manner.
To determine if any metabolic pathways were specifically enriched in the A. nidulans
CIs in comparison to levels in the reference strain, pathway enrichment analyses were
carried out on the metabolome data from glucose-, ethanol-, acetate-, and mucin-
grown cultures. In all tested carbon sources, with the exception of mucin for isolate
SP-2605-48, there was significant enrichment for aminoacyl-tRNA biosynthesis (Table 2).
The pathway constituting the metabolism of arginine and proline was significantly
enriched in both clinical isolates when they were grown in the presence of glucose and
ethanol and in isolate SP-2605-48 when it was incubated in mucin-rich medium
(Table 2). When acetate was used as the sole carbon and energy source, enrichment of
the metabolism of these amino acids was not observed (Table 2). In addition, metab-
olites identified for strain SP-2605-48 in the presence of mucin and ethanol showed
pathway enrichment in nitrogen metabolism (Table 2). In agreement with the afore-
mentioned differences in amino acid quantities, these results suggest that the CIs
exhibit differences in nitrogen metabolism in a carbon source-independent manner
compared to that of the reference strain.
The A. nidulans clinical isolates are more sensitive to hydrogen peroxide-
induced oxidative stress and cell wall-perturbing agents than the reference strain.
Due to the significant metabolic differences observed between the CIs and the refer-
ence strain in the presence of physiologically relevant carbon sources and given that
primary metabolism (carbon source utilization) has been shown to impact virulence
factors in opportunistic pathogenic fungi (28, 29), we hypothesized that similar differ-
ences could be observed in the presence of physiologically relevant stress conditions.
One such virulence factor is the fungal cell wall, which is crucial for protection,
interaction with, and modulation or evasion of the host immune system (30). In
addition, cell wall polysaccharide composition is dependent on carbon source primary
metabolism (28, 29, 31).
The production of reactive oxygen species (ROS), such as H2O2, and subsequent
augmentation of cellular oxidative stress are strategies employed by the mammalian
immune system to combat potential invading pathogenic microorganisms (14). The A.
nidulans reference strain and the two CIs were therefore grown in the presence of
hydrogen peroxide (H2O2) and the oxidative stress-inducing compound menadione.
Both CIs were more sensitive (reduced growth) to high concentrations of H2O2 (see Fig.
S3A at https://doi.org/10.6084/m9.figshare.11973936) whereas they were more resis-
tant to menadione than the reference strain (see Fig. S3B). Furthermore, iron seques-
tration and elevated body temperature are additional physiological stress responses
exerted by the host to prevent and/or control infection progression (32). Strains were








Acetate Aminoacyl-tRNA biosynthesis; alanine,
aspartate, and glutamate metabolism;
cyanoamino acid metabolism; valine,
leucine, and isoleucine metabolism;
glycine, serine and threonine metabolism
Aminoacyl-tRNA biosynthesis, beta-
alanine metabolism
Ethanol Aminoacyl-tRNA biosynthesis, arginine
and proline metabolism
Aminoacyl-tRNA biosynthesis, arginine
and proline metabolism, nitrogen
metabolism, alanine, aspartate, and
glutamate metabolism
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therefore grown on iron-poor, glucose-rich minimal medium supplemented without
(control) or with the iron chelators bathophenanthroline disulfonate (BPS) and ferrozine
(see Fig. S3C), as well as in the presence of increasing temperatures (see Fig. S3D).
Growth rates of all strains were similar under these conditions although strain MO80069
grew slightly more in the presence of the iron chelators (see Fig. S3C). Last, growth of
all strains was assessed in the presence of the cell wall-perturbing agents caspofungin,
Congo red (CR), and calcofluor white (CFW). The echinocandin caspofungin is a
noncompetitive inhibitor of the cell wall enzyme -1,3-glucan synthase (33) while CR
and CFW bind to glucan and chitin chains, respectively (34, 35). CR and CFW therefore
interfere with the cross-linking of cell wall polysaccharides, resulting in a reduction of
cell wall stability. Both clinical isolates were more sensitive to low and medium
concentrations of caspofungin than the reference strain, whereas all three strains grew
similarly in the highest tested caspofungin concentration (8 g/ml) (Fig. 3A). Similarly,
both clinical strains were more sensitive to lower concentrations of CR whereas no
significant difference in growth levels was observed in the presence of 50 g/ml CR
between all strains (Fig. 3B). In contrast, the CIs had significantly reduced growth in the
presence of CFW compared to that of the reference strain (Fig. 3C).
In summary, the aforementioned results suggest strain-specific differences in the
response to different physiological stress conditions and imply that the two A. nidulans
CIs are more sensitive to cell wall-perturbing agents than the reference strain.
The A. nidulans clinical isolates do not display increased resistance to azoles
and amphotericin B. Since both CIs showed increased susceptibility to caspofungin,
an echinocandin that is being used as a second-line treatment for fungal infections (33),
and to other cell wall-perturbing agents, we expanded our analyses to include two
additional antifungal drugs classes. Specifically, we followed guidelines for the diag-
nosis and management of aspergillosis, which, in most cases, recommends treating
aspergillosis with azoles and polyene drugs (11), both of which are known to interfere
with the biosynthesis or physicochemical properties of fungal membrane sterols (10).
Therefore, we determined the MICs of the azoles voriconazole and posaconazole and
the polyene amphotericin B for all three strains. No differences in the MICs among all
strains to these drugs was observed (Table 3).
Cleistothecium formation is impaired in the A. nidulans SP-2605-48 strain. A.
nidulans is known for its easily inducible sexual cycle, which serves as a laboratory-
FIG 3 The A. nidulans clinical isolates are more sensitive to the cell wall-perturbing agents. (A to C) Strains were grown from 105 spores on glucose minimal
medium supplemented with increasing concentrations of caspofungin, Congo red, and calcofluor white for 5 days at 37°C. Standard deviations represent
biological triplicates in a two-way ANOVA test, comparing growth of the clinical isolates to growth of the FGSC A4 reference strain (*, P  0.05; **, P  0.01;
***, P  0.001; ****, P  0.0001).
TABLE 3 MICs of voriconazole, posaconazole, and amphotericin B for the A. nidulans
clinical isolates MO80069 and SP-2605-48 and the FGSC A4 reference strain
Strain
MIC (g/ml)
Voriconazole Posaconazole Amphotericin B
FGSC A4 0.25 1.0 2.0
MO80069 0.25 1.0 2.0
SP260548 0.25 1.0 2.0
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based molecular tool for strain construction and studying fungal sexual reproduction
(36). To further characterize A. nidulans CI biology, we performed self- and outcrosses
for each clinical strain and the reference strain (control) at 30 and 37°C to assess
whether A. nidulans CIs are able to undergo sexual reproduction.
Strains were first crossed with themselves (self-crosses) at 30°C and 37°C, and
cleistothecium formation was observed for all strains at both temperatures, except for
strain SP-2605-48 at 37°C (Table 4). Density of cleistothecia (number of cleistothecia/
square centimeter) also varied between strains in a temperature-dependent manner,
with the clinical isolates forming fewer cleistothecia per square centimeter than the
reference strain at 30°C and 37°C (Table 4). In addition, no difference in levels of
ascospore viability was observed among strains (Table 4).
Outcrosses were performed by crossing the pyrG (requirement for uridine and uracil)
auxotrophic strains MO80069 and SP-2605-48 with the paba (requirement for para-
aminobenzoic acid)-deficient strain R21XR135 (Table 5). Strain MO80069 produced
cleistothecia at both 30 and 37°C whereas strain SP-2605-48 did not produce any
cleistothecia under any of the tested conditions. Density of cleistothecia was very low
at 30°C (1.25 cleistothecia/cm2) but increased to the same number observed for the
self-crosses at 37°C, with high ascospore viability in all cases (Table 4).
Identification of SNPs and copy number variations in the A. nidulans clinical
isolate genomes. The aforementioned phenotyping and metabolomics results indicate
differences between the strains that affect traits such as nutrient source utilization and
resistance to different stresses. These results are in agreement with studies in A.
fumigatus that have described great strain heterogeneity in traits such as growth,
fitness, and enzyme secretion between different environmental and clinical isolates (24,
37). Indeed, the number of single nucleotide polymorphisms (SNPs), obtained during
strain pairwise comparison, in the genomes of different A. fumigatus strains range
TABLE 4 Cleistothecium formation and density and ascospore viability resulting from





of cleistothecia/cm2) Ascospore viability (%)
30 A4  A4 Yes 15.0  0.81 91.83  3.53
MO  MO Yes 7.0  1.35 92.83  3.96
SP  SP Yes 0.25  0.25 89.83  3.51
MO  R21 Yes 1.25  0.25 94.83  3.85
SP  R21 No
37 A4  A4 Yes 9.75  1.43 90.67  3.62
MO  MO Yes 5.25  1.31 92.5  2.76
SP  SP No
MO  R21 Yes 5.0  0.40 92.5  1.28
SP  R21 No
aA4, FGSC A4 reference strain; MO, MO80069 clinical isolate; SP, SP-2605-48 clinical isolate; R21, R21XR135,
paba-deficient strain.
TABLE 5 Strains used in this study
Strain Genotype Source Reference
FGSC-A4 Glasgow wild type (veA) Soil 36
MO80069 Wild type, clinical
isolate
Bronchoalveolar lavage




SP-2605-48 Wild type, clinical
isolate




R21XR135 pabaA1 yA2 NAa This study
MO80069 pyrG pyrG89 This study This study
SP-2605-48 pyrG pyrG89 This study This study
mpkA strain akuB mpkA::ptrA PTR NA 75
aNA, not applicable.
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between 13,500 (24) and 50,000 (38, 39). Strain heterogeneity has therefore mainly
been investigated in environmental and clinical isolates of A. fumigatus, whereas similar
studies have not been carried out for A. nidulans isolates. We therefore decided to
determine differences at the genomic level by sequencing the genomes of our two A.
nidulans CIs and comparing the sequences to the sequence of the FGSC A4 reference
genome.
The genomes of MO80069 and SP-2605-48 aligned at 98.3% and 97.4%, respectively,
to the genome of the reference strain FGSC A4, with 99.8% nucleotide identity. On the
other hand, 1.5% and 1.9% of the A4 assembled genome did not align to the MO80069
and SP-2605-48 genomes, respectively, indicating differences among the genomes of
all three strains.
A total of 12,956 and 12,399 SNPs with respect to the A4 reference genome were
detected in the genomes of MO80069 and SP-2605-48, respectively (Table 6; see also
Table S2 at https://doi.org/10.6084/m9.figshare.11973936). When the genome of SP-
260548 was compared to the genome of MO80069, 12,836 SNPs were detected
(Table 6; see also Table S2). Each SNP mutation was classified as either high, moderate,
or low according to its impact on the DNA codon frame and amino acid sequence.
High-impact-type mutations encompass frameshift mutations and stop codon gain/
loss, whereas missense mutations, resulting in amino acid changes, are considered
moderate-impact-type mutations. Low-impact-type mutations contain all synonymous
mutations and mutations within gene introns and untranslated regions (UTRs). The
genome of MO80069 contained 501 high-impact mutations, 6,271 missense (moderate
impact) mutations, and 6,184 synonymous (low impact) mutations in comparison to the
sequence of the reference genome (Table 6; see also Table S2). In the genome of
SP-2605-48, 465 high-impact mutations, 5,896 moderate-impact mutations, and 6,038
low-impact mutations were detected in comparison to the sequence of the reference
genome (Table 6; see Table S2). When the genomes of both CIs were compared, 426
high-impact mutations, 6,288 missense mutations, and 6,122 synonymous mutations
were detected (Table 6; see also Table S2 at the URL mentioned above). All nonsyn-
onymous mutations were distributed throughout the genomes of both CIs, and no
clear pattern in mutation accumulation could be observed for any of the 8 chromo-
somes (Fig. 4 and 5).
In addition, the genomes of both CIs were screened for large-scale (	50 bp)
insertions and deletions (indels). In total, 1,169 large-scale indels, consisting of anything
between 3 bp to 23 kbp in size, were detected among the eight chromosomes of the
CIs compared to the genome of the reference strain (see Table S3). Of these, 348 indels
were specifically located in the genome of MO80069, 446 indels were found in the
genome of SP-2605-48 only, and 375 indels were located in the genomes of both CIs
(Table 6; see also Table S3). The majority of these indels were insertions (Table 6). Of the
375 indels found in the genomes of both CIs, 227 (60.5%) indels differed between the
TABLE 6 Type and number of SNPs and long indels detected between the genomes of the A. nidulans clinical isolates MO80069 and SP-
2605-48 and compared to the FGSC A4 reference genome
Mutation type
No. of mutations
MO80069 vs FGSC A4 SP-2605-48 vs FGSC A4 SP-2605-48 vs MO80069
SNPs
Stop codon gain/loss 149 110 170
Frameshift 352 355 256
Missense 6,271 5,896 6,288
Synonymous 6,184 6,038 6,122
Total 12,956 12,399 12,836
Indels
Insertions 234 308 222
Deletion 114 138 207
Total 348 446 375
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two strains, with the remaining 148 indels being identical for both strains (see Table S3
at the URL mentioned above).
The A. nidulans clinical isolates are defective in MpkA accumulation in re-
sponse to cell wall stress. As this work aimed to characterize metabolic utilization of
physiologically relevant carbon and lipid sources in A. nidulans CIs, including acetate
and fatty acids, we screened genes encoding proteins important for carbohydrate and
lipid utilization, cell wall biosynthesis/remodeling, and sexual reproduction for the
presence of any of the aforementioned moderate- and high-impact mutations (see
Table S4 at the URL mentioned above). Moderate-impact (missense) mutations were
detected in three genes (hxkA, swoM, and pfka), encoding proteins involved in glyco-
lysis (hexokinase, glucose-6-phosphate isomerase, and 6-phosphofructokinase) in both
CIs, whereas four and six missense mutations were found in two genes (idpA and mdhA)
encoding the enzymes isocitrate dehydrogenase and malate dehydrogenase of the
tricarboxylic acid cycle in the genomes of MO80069 and SP-2605-48, respectively (see
Table S4). Similarly, several moderate-impact mutations were found in genes encoding
enzymes required for C2-associated metabolism (acetate, ethanol, and fatty acid),
including farA (transcription factor regulating fatty acid utilization) and farB (transcrip-
tion factor regulating the utilization of short-chain fatty acids) in both CIs, facA
(acetyl-coenzyme A [CoA] synthase), acuM (transcriptional activator required for glu-
coneogenesis), and alcM (required for ethanol utilization) in SP-2605-48, and echA
(enoyl-CoA hydratase) in MO80069 (see Table S4). Genes encoding proteins that
function in the glyoxylate cycle also contained missense mutations in both CIs (see
Table S4). Furthermore, a frameshift mutation was detected in both CIs in acuL,
encoding a mitochondrial carrier involved in the utilization of carbon sources that are
FIG 4 Diagram depicting the location of all detected nonsynonymous single nucleotide polymorphisms (SNPs) on the 8 chromosomes (Chr I to Chr VIII) of the
A. nidulans clinical isolates SP-2605-48 and MO80069 in comparison to the FGSC A4 reference genome.
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metabolized via the Krebs cycle (40) (see Table S4 at the URL mentioned above). The
aforementioned mutations could underlie the observed differences in phenotypic
growth in the presence of different carbon and lipid sources.
Due to the absence of cleistothecium formation in strain SP-2605-48, we wondered
whether this strain contained any mutations in genes encoding proteins required for A.
nidulans sexual reproduction. We found 11 and 13 mutations in 7 and 9 genes related
to mating in the MO80069 and SP-2605-48 genomes, respectively (see Table S4). These
mutations include missense and frameshift mutations in genes involved in the percep-
tion of light and dark (ireA, ireB, cryA, veA, and velB), mating processes (cpcA, rosA, and
nosA), and signal transduction (gprH and gprD) (see Table S4). Indeed, rosA was absent
in both CIs whereas ireA was missing from the genome of SP-2605-48. RosA is a
transcriptional repressor of sexual development (41) whereas IreA is a transcription
factor required for the blue light response, important for developmental processes,
including mating.
Last, as both CIs were sensitive to cell wall-perturbing agents, we screened for
mutations in genes encoding enzymes involved in cell wall biosynthesis and degrada-
tion. Compared to the FGSC A4 reference genome, we found 159 and 90 mutations in
40 and 34 genes involved in cell wall biosynthesis, integrity, and signaling in the
genomes of MO80069 and SP-2605-48, respectively (see Table S4 at https://doi.org/10
.6084/m9.figshare.11973936). The majority of these mutations were moderate-impact
missense mutations in genes that encode components required for 1,3-- and -glucan
and chitin synthesis and degradation, including various types of glucanases, chitinases,
and chitin synthases (see Table S4). However, 17 (MO80069) and 9 (SP-2605-48)
mutations were high-impact-level mutations which occurred in genes AN0550 (putative
glucan 1,3-beta-glucosidase), AN0509 (putative chitinase), AN0517 (putative chitinase),
AN0549 (putative chitinase), AN9042 (putative alpha-1,3-glucanase), AN6324 (putative
-amylase), AN4504 (putative endo-mannanase), and AN0383 (putative endo-mannanase)
FIG 5 Diagram depicting the location of all detected small deletions on the 8 chromosomes (Chr I to Chr VIII) of the A. nidulans clinical isolates SP-2605-48
and MO80069 in comparison to the FGSC A4 reference genome. Also shown are the locations of putative transposons in the A. nidulans reference genome.
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(see Table S4). In addition, small frameshift mutations were detected in three genes
encoding the mitogen-activated protein kinase (MAPK) kinase BckA (AN4887), the
MAPK MpkA (AN5666), and the transcription factor RlmA (AN2984) (see Table S4). In A.
fumigatus, BckA and MpkA are components of the cell wall integrity (CWI) pathway,
which ensures the integrity of the cell wall and is activated in response to different cell
wall stresses, including those exerted by cell wall-targeting antifungal drugs (42). RlmA
was shown to act downstream of MpkA, regulating cell wall biosynthesis-related genes,
and this transcription factor is also involved in the direct regulation of MpkA (43).
Mutation in rlmA was observed only in the genome of strain SP-2648-05.
In order to determine whether the observed frameshift mutations had an impact on
CWI signaling, we carried out Western blotting of phosphorylated MpkA in the pres-
ence of NaCl-induced cell wall stress in all three A. nidulans strains. Phosphorylated
MpkA levels were normalized by total cellular MpkA. Low levels of phosphorylated
MpkA were detected in the absence of NaCl in all three strains, but whereas MpkA
protein levels significantly increased upon cell wall stress in the FGSC A4 reference
strain, no phosphorylated MpkA could be detected in either CI (Fig. 6). These results
suggest that the observed frameshift mutations in mpkA had an effect on MpkA protein
levels in the presence of cell wall stress, potentially being (one of) the cause(s) for the
observed increased sensitivity to cell wall-perturbing agents.
The A. nidulans clinical isolates do not display increased resistance to in
vitro-mediated killing by different types of macrophages and neutrophils. Due to
the observed phenotypic and genotypic differences, we wondered whether the CIs
were different in virulence from the reference strain. Virulence was first characterized
under a variety of in vitro conditions. Macrophages play an essential role in clearing
Aspergillus species conidia from the lung (8), whereas neutrophils are predicted to
primarily be responsible for eliminating fungal hyphae (39). To determine whether any
strain-specific differences exist in macrophage-mediated phagocytosis and killing, the
respective assays were carried out for all three strains in the presence of murine
wild-type and gp91phox knockout (CGD) macrophages. Macrophages from CGD pa-
tients are impaired in eliminating conidia from the lung environment, thus rendering
the host more susceptible to fungal infections (20). Both types of macrophages
phagocytosed a significantly higher number of conidia from both A. nidulans clinical
isolates (75%) than the reference strain (50%) (Fig. 7A). Indeed, conidia from all
three A. nidulans strains had increased levels of viability after phagocytosis by gp91phox
knockout macrophages than wild-type macrophages, confirming the inability of this
type of macrophage to efficiently kill fungal conidia (Fig. 7B). Despite increased
phagocytosis of both CIs, no difference in conidial viability levels was observed for
strain MO80069 compared to the level of the reference strain, whereas wild-type but
FIG 6 MpkA is not phosphorylated in the A. nidulans clinical isolates MO80069 and SP-2605-48 in the
presence of NaCl-induced cell wall stress in contrast to MpkA levels in the FGSC A4 reference strain.
Strains were grown from 1  107 spores in complete medium for 16 h (control, 0 min) at 37°C before 0.5
M NaCl was added for 10 min (10=) and 30 min (30=). Total cellular protein was extracted, and Western
blotting was carried out probing for phosphorylated MpkA. Signals were normalized by the amount of
total MpkA present in the protein extracts, and cellular extracts from the ΔmpkA strain were used as a
negative control.
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not CGD macrophages succeeded in killing significantly more SP-2605-48 conidia
(Fig. 7B).
When challenged with human polymorphonuclear (PMN) cells, fungal survival was
reduced approximately 80% for all three A. nidulans strains, indicating that the neu-
trophils were actively killing the hyphal germlings (Fig. 7C). No difference in strain
survival rates was observed for the CIs (Fig. 7C). These results suggest that the A.
nidulans CIs do not have higher survival rates in the presence of macrophages and
neutrophils.
Virulence of the A. nidulans clinical isolates depends on the host immune
status. We determined the virulence of both A. nidulans CIs in animal models with
different immune statuses. As it is well known that A. fumigatus strain-specific virulence
is highly dependent on the type of host immunosuppression and model (24, 37, 43), we
sought to determine if this would also be the case for A. nidulans. The virulence of A.
nidulans CIs was assessed in both zebrafish and murine models of pulmonary and
invasive aspergillosis. Furthermore, the immune system of each animal was manipu-
lated in order to give rise to either immunocompetent, CGD, or neutropenic/neutro-
philic models. As with patients, CGD models of both mice (19) and zebrafish (21) are
very susceptible to A. nidulans infections. In both immunocompetent- and CGD-type
zebrafish and mice, no difference in virulence levels between the A. nidulans clinical
isolates and the reference strain was observed (Fig. 8A to D). However, the CI MO80069
was significantly more virulent in neutropenic mice and zebrafish with impaired
neutrophil function than the reference strain, whereas no difference in virulence was
observed for strain SP-2605-48 (Fig. 8E and F). These results suggest that, as in A.
fumigatus, A. nidulans virulence depends on the strain and the host immune status.
DISCUSSION
Aspergillus nidulans is a saprophytic fungus that can act as an opportunistic human
pathogen in a host immune status- and genetic condition-dependent manner (15, 18,
44). Infection with A. nidulans is prevalent in patients with chronic granulomatous
disease (CGD), and isolates have mainly been characterized in the context of this
disorder (14, 15). Studies on A. nidulans virulence have been carried out in CGD models
(animal and cell culture), and virulence characteristics have been compared to those of
the primary human opportunistic fungus A. fumigatus (20, 21, 45, 46). A. fumigatus
FIG 7 The A. nidulans clinical isolates MO80069 and SP-2605-48 do not present increased survival in the presence of macrophages and neutrophils. (A)
Percentage of phagocytized conidia by murine wild-type and gp91phox knockout macrophages. Macrophages were incubated for 1.5 h with conidia from the
respective strains before phagocytized conidia were counted. (B) CFU counts as a measure of conidium viability after passage through wild-type (wt) and
gp91phox knockout macrophages. Macrophages were incubated with the respective conidia for 1.5 h before they were lysed, and contents were plated on
complete medium. (C) Percentage of viable hyphal germlings after incubation for 16 h with neutrophils from healthy human donors. Strain viability was
calculated relative to incubation without PMN cells, which was set at 100% for each sample. Standard deviations represent biological triplicates in a one-way
ANOVA test with Tukey’s posttest (*, P  0.05; **, P  0.01, for results for the clinical isolates compared to those for FGSC A4; #, P  0.05, for a comparison of
results for the two types of macrophages in the same strain).
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infection biology and characterization of strains that were isolated from immunocom-
promised patients under different conditions have received considerable attention in
recent years (24, 37, 47), whereas similar studies into other pathogenic Aspergillus spp.
have been neglected although it is becoming apparent that non-A. fumigatus species,
including cryptic Aspergillus species, also contribute to host infection and invasion (7).
This work therefore aimed at providing a detailed phenotypic, metabolic, genomic, and
virulence characterization of two A. nidulans clinical isolates (CIs) that were isolated
from non-CGD patients.
The first CI (MO80069) was isolated from a patient with breast carcinoma and
pneumonia whereas the second CI (SP-2605-48) was obtained from a patient with cystic
fibrosis who underwent lung transplantation. Genome sequencing confirmed these
strains to be A. nidulans sensu stricto, and growth of these strains was characterized in
FIG 8 A. nidulans strain-specific virulence depends on the host immune status. The virulence of the A. nidulans
clinical isolates MO80069 and SP-260548 was tested in murine (A, C, and E) and zebrafish (B, D, and F) models of
pulmonary and invasive aspergillosis. Animals were manipulated in order to give rise to either immunocompetent
(A and B), CGD (chronic granulomatous disease) (C and D), or neutropenic (E)/neutrophilic (F) models. Shown are
survival curves for each immunosuppression condition and animal model. No difference in virulence levels was
detected for all strains in both immunocompetent and CGD mice. Strain MO80069 was significantly more virulent
in neutropenic mice and neutrophilic zebrafish. **, P  0.01; ****, P  0.0001 for a comparison of the values for the
clinical isolates to those of the FGSC A4 reference strain in a two-way ANOVA test with Tukey’s posttest.
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the presence of physiologically relevant carbon sources. Fungi require carbon sources
in large quantities in order to sustain biosynthetic processes and actively scavenge for
them in their environment, including mammalian hosts (24). Available carbon sources
vary according to the patient’s immune status and disease progression with, for
example, corticosteroid treatment resulting in an increase of fatty and amino acid
concentrations and a decrease of glucose levels in mouse lungs (22). Growth of the two
A. nidulans strains in the presence of different carbon sources differed significantly from
growth of the reference strain, with increased biomass accumulation being observed in
the presence of alternative (ethanol, lipids, and amino acids) carbon sources and
reduced growth in the presence of glucose. The observed phenotypic differences were
corroborated by metabolic and genomic data which found a number of missense and
high-impact mutations in genes encoding enzymes required for alternative carbon
source and glucose utilization. These included missense mutations in genes encoding
glycolysis- and citric acid cycle-related enzymes as well as five missense mutations in
the transcription factor-encoding gene farA, which regulates the utilization of short-
and long-chain fatty acids. Whether these mutations alone and/or in combination with
other identified gene mutations are responsible for the observed growth phenotypes
remains to be determined. Nevertheless, it is noteworthy that these mutations are
found in both CIs, suggesting that these strains are able to grow well in nutrient-poor
environments, such as the lung, compared to growth of the reference strain, which was
isolated from the soil environment. Furthermore, whether these mutations are a result
of adaptation to the host environment also remains subject to future investigations.
In addition, we also assessed the resistance of these strains to a variety of physio-
logically relevant stress conditions by growing them in the presence of oxidative stress
and cell wall stress-inducing compounds, high temperature, iron limitation, and anti-
fungal drugs. Some minor strain-specific differences were observed under these con-
ditions, but the CIs were not significantly more resistant to these conditions, including
exposure to azole- and polyene-type anti-fungal drugs, than the reference strain. It is
possible that the patient-specific lung environment, biofilm formation, and/or interac-
tions with other microorganisms may result in protection of these stresses, thus
resulting in strains that do not have increased stress tolerance. In contrast to Candida
albicans, an opportunistic fungal pathogen which was shown to interact with the
Gram-negative bacterium Pseudomonas aeruginosa to promote colonization of patients
with cystic fibrosis in a condition-dependent manner (48), such interactions have not
been investigated for Aspergillus spp. Aspergillus interspecies interaction in lung micro-
biomes of patients with and without cystic fibrosis therefore remains an intriguing
aspect of fungal pathobiology that warrants further characterization.
In contrast, both A. nidulans clinical strains were significantly more sensitive to the
cell wall-perturbing agents calcofluor white, Congo red, and caspofungin (33–35) than
the reference strain. These results suggest differences in cell wall composition and/or
organization between the clinical isolates and the reference strain. When the respective
genome sequences were analyzed, we found 159 and 90 mutations in 40 and 34 genes
encoding enzymes required for cell wall glucan and chitin biosynthesis and degrada-
tion in strains MO80069 and SP-2605-48, respectively, compared to the genome of the
FGSC A4 reference strain. Of particular interest was the identification of high-impact
mutations in the genes bckA, mpkA, and rlmA, which encode components of the CWI
signaling pathway. Indeed, Western blotting confirmed the absence of MpkA phos-
phorylation in the CIs in the presence of cell wall stress. These results suggest that the
observed gene mutations cause an altered CWI response, resulting in increased sensi-
tivity to cell wall-perturbing agents. The physiological relevance of these findings
remains to be determined.
Aspergillus nidulans is characterized by an easily inducible sexual cycle as well as by
undemanding laboratory-based cultivation and genetic manipulation conditions and
has extensively been used as a model organism to study sexual reproduction and
developmental processes (49). Nevertheless, it is unknown whether these traits can also
be applied to A. nidulans clinical strains, and this work therefore assessed the ability of
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the two CIs to form cleistothecia in self- and outcrosses. Strain MO80069, similar to the
reference strain, produced cleistothecia and viable ascospores under all tested condi-
tions, whereas strain SP-2605-48 formed cleistothecia and viable ascospores only in
self-crosses at 30°C and not at 37°C. This suggests that a certain degree of heteroge-
neity exists with regard to sexual reproduction in A. nidulans clinical strains although a
bigger sample size and further studies are required in order to confirm this. Temper-
ature has been shown to influence cleistothecium formation in Aspergillus spp., with
lower temperatures of 30°C resulting in a higher number of formed cleistothecia (50).
Furthermore, we cannot exclude the possibility that strains such as SP-2605-48 may
require a different condition for sexual reproduction as it is determined by a series of
environmental factors that can either activate or repress sexual development (50). This
work identified six missense mutations in four genes (veA, cpcA, fhbB, and gprH)
encoding enzymes involved in sexual development, and gene ireA was absent in the
SP-2605-48 genome compared to the genomes of strains FGSC-A4 and MO80069.
Genes veA, cpcA, fhbB, and ireA encode proteins that are involved in the perception of
environmental signals (50), favoring the hypothesis that SP-2605-48 may require dif-
ferent/specific conditions for cleistothecium production, although it remains to be
determined whether the aforementioned mutations and ireA are directly linked to the
absence of cleistothecium production in strain SP-2605-48 under the conditions tested
here.
Last, this work examined the in vivo virulence of the A. nidulans CIs in different
animal models with a variety of immune statuses as A. fumigatus strain-specific viru-
lence is highly dependent on the type of host immunosuppression and model (24, 37,
51). No difference in virulence levels was observed in immunocompetent and CGD
murine and zebrafish models whereas strain MO80069 was significantly more virulent
in a zebrafish with impaired neutrophil function and a neutropenic murine model of
invasive aspergillosis than strains FGSC A4 and SP-2605-48. These results suggest that
neutrophil recruitment and function at the site of infection are important for controlling
A. nidulans infection in both vertebrates. Furthermore, results are in agreement with
studies on A. fumigatus, which show that virulence is as much a strain-dependent as a
host-dependent trait (24, 37, 39, 51). Furthermore, the tested phenotypes and genome
mutations appear not to correlate with strain virulence although sample size has to be
increased in order to confirm this in future studies. Aspergillus infection biology of
mammalian hosts is a multifactorial and multifaceted process that depends not only on
strain-specific virulence traits (30) but also on the genetic composition of the host and
status of the immune system (52). Furthermore, the composition and interspecies
interactions of the lung microbiome also influence pathogenicity of a given microor-
ganism, with interactions between different species shown to influence host immune
responses (49, 53). A. fumigatus is the main etiological agent of Aspergillus-related
diseases and is predominantly present in the lung environment compared to the sites
of infections caused by Aspergillus spp. (7). It is therefore possible that other Aspergillus
spp., such as A. nidulans, remain largely undetected in the lung environment due to the
predominant nature and/or inhibitory function of other fungal species and where they
can grow without the necessity to evolve and adapt to extreme stress conditions. The
prevalence and virulence of non-A. fumigatus species therefore remains a highly
interesting and somewhat neglected topic that warrants future detailed studies. In
summary, this is the first study that presents extensive phenotypic, metabolic, genomic,
and virulence characterization of two A. nidulans clinical isolates. Just as in A. fumigatus,
strain heterogeneity exists in A. nidulans clinical strains that can define virulence traits.
Further studies are required to fully characterize A. nidulans strain virulence traits and
pathogenicity.
MATERIALS AND METHODS
Ethics statement. The principles that guide our studies are based on the Declaration of Animal
Rights ratified by the UNESCO on the 27 January 1978 in its 8th and 14th articles. All protocols used in
this study were approved by the local ethics committee for animal experiments from Universidade de
São Paulo, Campus Ribeirão Preto (permit number 08.1.1277.53.6). All adult and larval zebrafish proce-
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dures were in full compliance with NIH guidelines and approved by the University of Wisconsin—
Madison Institutional Animal Care and Use Committee (no. M01570-0-02-13).
Strains, media, and growth conditions. All strains used in this study are listed in Table 5. A. nidulans
strain FGSC A4 was used as a reference strain. In addition to culture macroscopic features and fungal
microscopic morphology analysis, whole-genome sequencing and phylogenetic analysis confirmed that
both clinical isolates are A. nidulans (see Fig. S4; all supplemental material is available at https://doi.org/
10.6084/m9.figshare.11973936). For phylogenetic tree construction, we compared CaM, BenA, RPB2, and
ITS ribosomal DNA (rDNA) sequences, identified using blastN implemented in BLAST, version 2.8.1 (54),
to sequences from other species in the Aspergillus section Nidulantes (55), using a maximum-likelihood
tree constructed with MEGA, version 10.1.1 (56). All strains were maintained in 10% glycerol at – 80°C.
Strains were grown in either complete medium (CM) or minimal medium as described previously (57).
Iron-poor MM was devoid of all iron and supplemented with 200 M concentrations of the iron chelators
bathophenanthrolinedisulfonic acid (4,7-diphenyl-1,10-phenanthrolinedisulfonic acid [BPS]) and 300 M
3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine (ferrozine). All growth was carried out at 37°C for
the indicated amounts of time, except where otherwise stated (Fig. 1 and 3; see also Fig. S3). Reagents
were obtained from Sigma-Aldrich (St. Louis, MO) except where otherwise stated. Radial growth was
determined by inoculating plates with 105 spores of each strain and incubation for 5 days before colony
diameter was measured. Where required, the oxidative stress-inducing compound menadione or the cell
wall-perturbing compounds Congo red (CR), caspofungin, and calcofluor white (CFW) were added in
increasing concentrations. All radial growth was expressed as ratios, dividing colony radial diameter (in
centimeters) of growth under the stress condition by colony radial diameter under the control (no stress)
condition. To determine fungal dry weight, strains were grown from 3  106 spores in 30 ml of liquid MM
supplemented with 1% (wt/vol) glucose, acetate, mucin, or Casamino Acids or 1% (vol/vol) ethanol,
Tween 20 and 80, or olive oil for 48 h (glucose) or 72 h (others) at 37°C and 150 rpm. All liquid and solid
growth experiments were carried out in biological triplicates.
Growth in the presence of H2O2 was carried out as serial dilutions (105 to 102 spores) in liquid CM in
24-well plates for 48 h in the presence of different concentrations of H2O2.
Metabolite analysis. Metabolome analysis was performed as described previously (58). Briefly,
metabolites were extracted from 5 mg of dry-frozen, mycelial powder of four biological replicates. The
polar phase was dried, and the derivatized sample was analyzed on a Combi-PAL autosampler (Agilent
Technologies GmbH, Waldbronn, Germany) coupled to an Agilent 7890 gas chromatograph coupled to
a Leco Pegasus 2 time-of-flight mass spectrometer (LECO, St. Joseph, MI). Chromatograms were exported
from the Leco ChromaTOF software, version 3.25, to the R software package (www.r-project.org). The
Target Search R package was used for peak detection, retention time alignment, and library matching.
Metabolites were quantified by the peak intensity of a selective mass and normalized by dividing the
value by the respective sample dry weight. Principal-component analysis was performed using the
pcaMethods bioconductor package (59, 60). Pathway enrichment analysis was carried out using Meta-
boAnalyst (https://www.metaboanalyst.ca/faces/ModuleView.xhtml) (61).
Determination of MICs. MICs of amphotericin B, voriconazole, and posaconazole were determined
by growing 104 spores/well in 96-well plates containing 200 l/well of RPMI medium and increasing
concentrations of the aforementioned compounds, according to the protocol elaborated by the Clinical
and Laboratory Standards Institute (62).
Induction of cleistothecium formation. Cleistothecium formation through self-crossing was in-
duced by growing the strains on glucose minimal medium (GMM) plates that were sealed airtight and
incubated for 14 days at 30 or 37°C. Plates were scanned for the presence of cleistothecia under a light
microscope. To assess ascospore viability, five cleistothecia of each strain were collected, cleaned on 4%
(wt/vol) agar plates, and resuspended in 100 l of water. Ascospores were counted, and 100 ascospores
were plated on GMM before CFU counts were determined. Cleistothecium density was determined
through counting the number of cleistothecia of a certain area and dividing the value by the area (in
square centimeters).
Cleistothecium formation through outcrossing was carried out as described previously (57). To
induce pyrG auxotrophy in strains MO80069 and SP-2605-48 (Table 1), they were grown on GMM plates
supplemented with 1.2 g/liter uridine and uracil (UU) and 0.75 mg/ml 5-fluoroorotic acid (FOA) in the
form of a cross until single colonies appeared. Auxotrophy was confirmed by growing strains on GMM
with and without UU before strains were crossed with strain R21XR135 (Table 1).
DNA extraction, genome sequencing, and detection of SNPs and indels. DNA was extracted as
described previously (57). Genomes were sequenced using 150-bp Illumina paired-end sequence reads
at the Genomic Services Lab of Hudson Alpha (Huntsville, AL). Genomic libraries were constructed with
the Illumina TruSeq library kit and sequenced on an Illumina HiSeq 2500 sequencer. Samples were
sequenced at greater than 180 coverage or depth.
The Illumina reads were processed with the BBDuk and Tadpole programs of BBMap release 37.34
(https://sourceforge.net/projects/bbmap/files/BBMap_37.34.tar.gz/download) to remove sequencing
adapters and phiX and to correct read errors.
Two different Illumina assemblies were performed with the trimmed reads, using platanus (63) and
sparseAssembler (64). Nanopore reads were first filtered for quality using Nanofilt (quality of 	7) and
then were corrected using Canu (65). Once corrected, a subset of reads covering 30 times the estimated
genome size of 30 Mb was selected, giving preference to the longest reads. DBG2OLC (66) was used with
each of the two Illumina assemblies and the subset of nanopore reads to perform two hybrid assemblies.
Independently, MaSuRCA (67) was used to perform a hybrid assembly using the raw nanopore and
Illumina reads. The three hybrid assemblies were then corrected using Pilon (68) for three rounds on each
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assembly. Ragout (69) was then used to fuse the three assemblies into one final assembly using the
assembly obtained with MaSuRCA as the base and the other two as references. This assembly was then
corrected again for three rounds using Pilon. The mitochondrial genome was obtained from the
discarded contigs of MaSuRCA.
The Aspergillus nidulans FGSC A4 genome sequence and gene predictions, were obtained from the
Aspergillus Genome Database (version s10-m04-r15 [http://aspgd.org/]). The processed DNA reads were
mapped to the FGSC A4 genome with minimap2, version 2.17 (https://github.com/lh3/minimap2), and
variants from the FGSC A4 sequence were called with Pilon, version 1.23 (https://github.com/
broadinstitute/pilon). Short indels and nucleotide polymorphisms were recovered from the Pilon VCF
files by filtering with vcffilter (https://github.com/vcflib/vcflib) to retain only calls with read coverage
deeper than 7, exactly one alternative allele, and an alternative allele fraction of at least 0.8. Longer indels
and sequence polymorphisms were recovered by searching the VCF files for the SVTYPE keyword.
Support for the detected indels was verified by mapping reads to a modified version of the reference
genome generated by Pilon. The read coverage depths over inserted sequences were compared to the
coverage of flanking sequences, and deletion sites were checked for breaks in read coverage. Sequence
variations inside predicted genes and their effects on predicted protein sequence were identified with
a custom Python script. The mitochondrial genome was obtained from the discarded contigs of
MaSuRCA. Due to its circular nature, the mitochondrial genome appeared repeated multiple times in a
single contig. Lastal (http://last.cbrc.jp/doc/last.html) was used to extract one single copy of the mito-
chondrial genome using the reference mitochondrion.
Detection of large genome deletions and insertions. Genome assemblies of the two clinical
isolates were aligned to the FGSC A4 reference genome with nucmer (70). The alignments were filtered
to keep only one-to-one matches. Strain-specific loci were detected by searching the alignment coor-
dinates table for regions of the A4 genome with no match in the clinical isolate genome. Large insertions
were detected by searching the alignment coordinate table for regions of the clinical isolate genomes
with no match in the A4 genome.
Identification of transposon-like regions in the FGSC A4 reference genome. Transposon-like
regions were identified by running Pfam (71) on the six translation frames of the complete genome
sequence. Regions containing any of the 14 domains typically known to be associated with transposable
elements (see Table S1 at the URL mentioned above) were collected. Inverted repeats longer than 50 bp
and separated by less than 5,000 bp were extracted and marked as potential miniature inverted-repeat
transposable elements (MITE). The Pfam and MITE locations were combined to form the transposon track.
Figure generation. DNAPlotter (72) was used to display the loci of all nonsynonymous SNPs and
large deletions identified in the two clinical strains compared to the reference genome of FGSC A4. In
addition, the locations of transposon-like regions in the A4 genome were also highlighted using
DNAPlotter.
Western blotting. Strains were grown from 1  107 spores at 37°C and 200 rpm in 50 ml of CM for
16 h before being exposed to 0.5 M NaCl for 0, 10, and 30 min. Total cellular proteins were extracted
according to Fortwendel and colleagues (73) and quantified according to Hartree (74).
For each sample, 60 g of total intracellular protein was run on a 12% (wt/vol) SDS-PAGE gel before
being transferred to a polyvinylidene difluoride (PVDF) membrane (GE Healthcare). Phosphorylated
MpkA or total MpkA was probed for by incubating the membrane with a 1:5,000 dilution of the
anti-phospho-p44/42 MAPK (9101; Cell Signaling Technologies) antibody or with a 1:5,000 dilution of the
p44-42 MAPK (Cell Signaling Technology) antibody overnight at 4°C, with shaking. Subsequently,
membranes were washed three times with TBS-T (2.423 g/liter Tris, 8 g/liter NaCl, 1 ml/liter Tween 20)
and incubated with a 1:5,000 dilution of an anti-rabbit IgG horseradish peroxidase (HRP) antibody (7074;
Cell Signaling Technologies) for 1 h at room temperature. MpkA was detected by chemiluminescence
using a Western ECL Prime (GE Healthcare) blot detection kit according to the manufacturer’s instruc-
tions. Films were submitted to densitometric analysis using ImageJ software (http://rsbweb.nih.gov/ij/
index.html). The amount of phosphorylated MpkA was normalized by the amount of total MpkA. The A.
fumigatus Δmpka strain was used as a negative control (Table 1) (75).
Isolation and differentiation of BMDM. Bone marrow-derived macrophages (BMDMs) were
isolated as described previously (76). Briefly, BMDMs were recovered from femurs of C57BL/6
wild-type and gp91phox knockout mice and were incubated in BMDM medium (RPMI medium [Gibco]
supplemented with 30% [vol/vol] L929 growth-conditioning medium, 20% inactivated fetal bovine
serum [FBS; Gibco], 2 mM glutamine, and 100 units/ml of penicillin-streptomycin [Life Technolo-
gies]). After 4 days, fresh medium was added for an additional 3 days before BMDMs were collected.
In vitro phagocytosis and killing assays. Phagocytosis and killing assays of A. nidulans conidia by
wild-type and gp91phox knockout macrophages were carried out according to Bom et al. (77) with
modifications. Twenty-four-well plates containing a 15-mm-diameter coverslip in each well (phagocytosis
assay) or without any coverslip (killing assay) and 2  105 macrophages per well were incubated in 1 ml
of RPMI-FBS medium (RPMI medium [Gibco] supplemented with 10% inactivated FBS[Gibco], 2 mM
glutamine, and 100 units/ml of penicillin-streptomycin [Life Technologies]) at 37°C in 5% CO2 for 24 h.
Wells were washed with 1 ml of phosphate-buffered saline (PBS) before the same volume of RPMI-FBS
medium supplemented with 1  106 conidia (1:5 macrophage/conidium ratio) was added under the
same conditions.
To determine phagocytosis, macrophages were incubated with conidia for 1.5 h before the super-
natant was removed, and 500 l of PBS containing 3.7% formaldehyde was added for 15 min at room
temperature (RT). Sample coverslips were washed with 1 ml of ultrapure water and incubated for 20 min
with 500 l of 0.1 mg/ml calcofluor white (CFW) to stain for the cell wall of nonphagocytized conidia.
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Samples were washed, and coverslips were viewed under a Zeiss Observer Z1 fluorescence microscope.
In total, 100 conidia were counted per sample, and the phagocytosis index was calculated. Experiments
were performed in biological triplicates.
To determine macrophage-induced killing of conidia, macrophages were incubated with conidia for
1.5 h before cell culture supernatants were collected and cytokine concentrations were determined.
Macrophages were then washed twice with PBS to remove all nonadherent cells and subsequently lysed
with 250 l of 3% (vol/vol) Triton X-100 for 10 min at RT. Serial dilutions of lysed samples were performed
in sterile PBS and plated onto CM and incubated at 37°C for 2 days before CFU counts were determined.
PMN cell isolation and spore germination assay. Human polymorphonuclear (PMN) cells from
fresh venous blood of healthy adult volunteers were isolated according to Drewniak et al. (78), with
modifications. Cells were harvested by centrifugation in isotonic Percoll, lysed, and resuspended in
HEPES-buffered saline solution. A. nidulans asexual spores were incubated with PMN cells (1  105cells/
ml; ratio of 500 PMN:1 conidium) in a 96-well plate overnight at 37°C in RPMI 1640 medium containing
glutamine and 10% fetal calf serum (Life). PMN cells were lysed in a solution of water and sodium
hydroxide (pH 11.0) (Sigma-Aldrich), and spore germination was determined using an MTT (thiazolyl
blue; Sigma-Aldrich) assay. Strain viability was calculated relative to incubation without PMN cells, the
level of which was set at 100% for each sample. The viability of A. nidulans germinated spores in the
presence of PMN cells was determined as described previously (32).
In vivo infections in immunocompetent, CGD, and neutrophilic zebrafish. We evaluated strain
virulence in an established zebrafish-aspergillosis model. Seventy-two wild-type larvae were used as an
immunocompetent model. Larvae with a dominant negative Rac2D57N mutation in neutrophils (mpx::
rac2D57N) (39) were used as a model of leukocyte adhesion deficiency, where neutrophils do not reach
the site of infection, and p22phox-deficient larvae [p22phox (sa11798)] were used as a chronic granulomatous
disease (CGD) model (21).
Spore preparation and conidium microinjection into the hindbrain of 2-day postfertilization (dpf)
larvae were performed as previously described (79). Briefly, after manual dechorionation of embryos, 3
nl of inoculum or PBS-control was injected into the hindbrain ventricle via the optic vesicle (50 conidia)
in anesthetized larvae at approximately 36 h postfertilization.
In vivo infections in immunocompetent, CGD, and neutropenic mice. Virulence of the A. nidulans
strains was determined in immunocompetent, CGD, and neutropenic mice. A. nidulans conidial suspen-
sions were prepared, and viability experiments were carried out as described previously (77). Eight- to
12-week-old wild-type (n 
 10) and gp91phox knockout (n 
 7) C57BL/6 male mice were used as
immunocompetent and CGD models, respectively. Neutropenia was induced in 7- to 8-week-old BALB/c
female mice (n 
 10, weighing between 20 and 22 g) with cyclophosphamide at a concentration of
150 mg per kg, administered intraperitoneally (i.p.) on days 4 and 1 prior to infection (day 0) and at
2 days postinfection. Hydrocortisone acetate (200 mg/kg) was injected subcutaneously on day 3 prior
to infection.
Mice were anesthetized and submitted to intratracheal (i.t.) infection as previously described (80)
with some minor modifications. Briefly, after i.p. injection of ketamine and xylazine, animals were infected
with 5.0  107 (immunocompetent) or 1  106 (CGD) conidia contained in 75 l of PBS (81) by surgical
i.t. inoculation, which allowed dispensing of the fungal conidia directly into the lungs. Neutropenic mice
were infected by intranasal instillation of 1.0  104 conidia as described previously (70). Phosphate-
buffered saline (PBS) was administered as a negative control for each murine model.
Mice were weighed every 24 h from the day of infection and visually inspected twice daily. The
endpoint for survival experimentation was identified when a 20% reduction in body weight was
recorded, at which time the mice were sacrificed.
Statistical analyses. All statistical analyses were performed using GraphPad Prism, version 7.00
(GraphPad Software, San Diego, CA), with a P value of  0.05 considered significantly different. A
two-way analysis of variance (ANOVA) was carried out on all stress response tests whereas a one-way
ANOVA with Tukey’s posttest was applied for growth in the presence of different carbon sources, for the
phagocytosis index, and for the PMN cell killing assay. Survival curves were plotted by Kaplan-Meier
analysis, and results were analyzed using a log rank test. All experiments were repeated at least twice.
Data availability. Short-read sequences for these strains are available in the NCBI Sequence Read
Archive (SRA) under accession numbers SRR10983230, SRR10983231, SRR10983232, and SRR10983233
and BioProject number PRJNA603646. Genomes were deposited in GenBank under accession numbers
JAAFYM000000000 and JAAFYL000000000.
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